Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LMF1 antisense RNA 1 (LMF1-AS1) is a gene that produces a long non-coding RNA (lncRNA), categorized as an antisense RNA overlapping or adjacent to the LMF1 gene. It does not encode a protein and is not itself directly considered a therapeutic target such as a receptor, enzyme, or transporter. Its function is not well characterized; however, like other antisense lncRNAs, LMF1-AS1 may influence the regulation of its corresponding sense gene (LMF1) or other nearby genetic elements, possibly affecting mRNA stability or transcriptional activity. Database records suggest an association with depressive disorder, but there is no evidence to date of drug targeting, biomarker status, nor a defined mechanism of action or safety concerns as a therapeutic target[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LMF1 antisense RNA 1 (LMF1-AS1).